Urogen Pharma Ltd.
URGN
Revenue
20.25M
▼-4.31M▼-17.55%
3 Months ChangeAssets
247.62M
▼-38.09M▼-13.33%
3 Months ChangeLiabilities
294.08M
▼-438.00k▼-0.1487%
3 Months ChangeFree Cash Flow
-42.07M
▼-10.33M▼-32.56%
12 Months ChangeRevenue/Cost Of Revenue
Loading...
Net Profit/Loss
Loading...
Assets/Liabilities
Loading...
Cash Flows
Loading...
Loading...
Loading...
Recent Quarterly and Annual Filings
2024-10-09
Form 8-K
ID: 0001193125-24-234808
2024-09-24
Form 8-K
ID: 0001193125-24-224801
2024-09-13
Form 8-K
ID: 0001193125-24-218868
2024-08-15
Form 8-K
ID: 0001193125-24-200993
2024-08-13
Form 10-Q
ID: 0001437749-24-026161
2024-08-13
Form 8-K
ID: 0001193125-24-199425
2024-08-08
Form 8-K
ID: 0001193125-24-197008
2024-06-18
Form 8-K
ID: 0001193125-24-163498
2024-06-13
Form 8-K
ID: 0001193125-24-160413
2024-05-13
Form 10-Q
ID: 0001437749-24-016116